# Design Therapeutics, Inc.: Form SCHEDULE 13D/A, filed Nov 18, 2025

- Company: [Design Therapeutics, Inc.](/companies/dsgn.md) (CIK 1807120)
- Form: SCHEDULE 13D/A
- Filed: 2025-11-18
- Accepted by EDGAR: Nov 18, 2025, 17:57 ET
- Period: not reported
- Accession: 0000935836-25-000710
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1807120/000093583625000710/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1807120/000093583625000710/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1807120/000093583625000710/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Nov 18, 2025.
Source: SEC EDGAR, the filing index for accession 0000935836-25-000710. Last ingested by Listed: Nov 4, 2026, 18:41 ET. No prices; not investment advice.